SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-026437
Filing Date
2023-06-05
Accepted
2023-06-05 17:15:58
Documents
12
Period of Report
2023-06-02
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rgnx-20230602.htm   iXBRL 8-K 75095
  Complete submission text file 0000950170-23-026437.txt   189129

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgnx-20230602_pre.xml EX-101.PRE 9447
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgnx-20230602_lab.xml EX-101.LAB 12806
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgnx-20230602.xsd EX-101.SCH 2460
6 EXTRACTED XBRL INSTANCE DOCUMENT rgnx-20230602_htm.xml XML 4522
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 23993798
SIC: 2836 Biological Products, (No Diagnostic Substances)